Navigation Links
Vitamin D found to fight placental infection
Date:12/1/2008

In a paper available at the online site of the journal Biology of Reproduction, a team of UCLA researchers reports for the first time that vitamin D induces immune responses in placental tissues by stimulating production of the antimicrobial protein cathelicidin.

The study involved exposing cultured human trophoblast cells to the active form of vitamin D, leading to production of cathelicidin and an increased antibacterial response in the trophoblast cells.

The team, headed by Dr. Martin Hewison, suspects that the ability of the placenta to synthesize cathelicidin varies widely among women. Their discovery suggests that placental innate immunity can be enhanced if pregnant women supplement their diets with vitamin D.

Induction of cathelicidin production by vitamin D may help the placenta stave off infection by a variety of pathogenic organisms, including staphylococcus, streptococcus, and E. coli bacteria. Vitamin D may also enhance and sustain this bacterial killing by protecting placental trophoblast cells from infection-associated cell death.

The significance of vitamin D in human reproduction has been recognized for the past 20 years, although its exact role has not been completely understood. This study presents a new mechanism for activation of innate immune responses in the placenta to protect it from infectious bacteria and sheds new light on the possible role of vitamin D in pregnancy and pregnancy-associated infection.


'/>"/>

Contact: Martin Hewison
mhewison@mednet.ucla.edu
Society for the Study of Reproduction
Source:Eurekalert

Page: 1

Related biology news :

1. Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease
2. Could vitamin D save us from radiation?
3. Lung airway cells activate vitamin D and increase immune response
4. Optimal dose of vitamin E maximizes benefits, minimizes risk
5. Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
6. Lack of vitamin D linked to Parkinsons disease
7. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
8. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
9. Dont forget the vitamin A when working with its carrier protein
10. Variant of vitamin D receptor gene linked to melanoma risk
11. Majority of osteoporosis patients not receiving calcium and vitamin D with treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... AURORA, Colo. (PRWEB) , ... January 11, 2017 ... ... in the journal Clinical Cancer Research show early promise of the investigational anti-cancer ... progressed despite a median 5 previous treatment regimens. Twenty-seven percent of these heavily ...
(Date:1/11/2017)... ... 11, 2017 , ... With sepsis claiming approximately 500,000 lives ... billion, healthcare systems are looking to provide better and faster care to ... are bacteria and the yeast pathogen Candida, which can lead to severe complications ...
(Date:1/11/2017)... Colorado (PRWEB) , ... January 11, 2017 , ... ... dynamic aqueous plasma technology platforms, announced today that the National Science Foundation (NSF) ... supplement for $500,000. The funds will be used to commercialize the Symbios Tubular ...
(Date:1/11/2017)... GAITHERSBURG, Md. , Jan. 11, 2017 /PRNewswire/ ... clinical-stage gene delivery company, announced today that its ... will present a talk entitled  "AdenoVerse™ platform for ... during the Biotech Showcase at the upcoming Phacilitate ... Miami , Florida.  Dr. Brough,s ...
Breaking Biology Technology: